KELLEY SCOTT 4
4 · Flexion Therapeutics Inc · Filed Mar 3, 2020
Insider Transaction Report
Form 4
KELLEY SCOTT
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2020-03-02+15,500→ 15,500 totalExercise: $15.78Exp: 2030-03-01→ Common Stock (15,500 underlying) - Award
Common Stock
2020-03-02+31,000→ 80,365 total
Footnotes (2)
- [F1]Represents restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan.
- [F2]Twenty-five percent (25%) of the shares shall vest on the one year anniversary of January 1, 2020 (the "Vesting Commencement Date") and thereafter one-forty-eighth (1/48th) of the total shares shall vest each month following the one year anniversary of the Vesting Commencement Date, so that all of the shares shall be vested four (4) years after the Vesting Commencement Date.